- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2012-03-12 15:10:25
- Reporting Period:
- Filing Date:
- Filing Date Changed:
- Accepted Time:
- 2012-03-12 16:10:25
- Original Submission Date:
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1325879||Aveo Pharmaceuticals Inc||AVEO||Pharmaceutical Preparations (2834)||000000000|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1486359||Jeno Gyuris||C/o Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
|Svp, Chief Scientific Officer||No||Yes||No||No|
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.03 to $13.10 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Insider Monkey Small Cap Strategy
Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!